These side effects can sometimes get better over time but, Shah said, at least 10% of patients who start these drugs have to be taken off of them because the side effects do not improve
The Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness (GRADE) study [16] found that GLP-1 RA (i.e., liraglutide) was significantly more effective in achieving and maintaining target levels of HbA1c compared with sulfonylureas (i.e., glimepiride) and DPP4i (i.e., sitagliptin) after an average follow-up of 5 years among those with T2D who were on metformin
These topics can become relevant when patients ask about resilience, healing support, or recovery after physical stress
Retrieved from Nijakowski, K., Jankowski, J., Gruszczyski, D., & Surdacka, A